| Primary |
| Hypertension |
56.8% |
| Diabetes Mellitus |
5.2% |
| Blood Pressure Increased |
4.9% |
| Attention Deficit/hyperactivity Disorder |
3.9% |
| Pain |
2.9% |
| Perineal Pain |
2.9% |
| Drug Detoxification |
2.6% |
| Restless Legs Syndrome |
2.3% |
| Essential Hypertension |
1.9% |
| Hot Flush |
1.9% |
| Spinal Anaesthesia |
1.9% |
| Blood Pressure |
1.6% |
| Chest Pain |
1.6% |
| Postoperative Analgesia |
1.6% |
| Abnormal Behaviour |
1.3% |
| Asthma |
1.3% |
| Colon Cancer |
1.3% |
| Depression |
1.3% |
| Hypothyroidism |
1.3% |
| Local Anaesthesia |
1.3% |
|
| Somnolence |
14.5% |
| Drug Ineffective |
11.7% |
| Hypotension |
11.7% |
| Hypertension |
10.3% |
| Blood Pressure Increased |
6.9% |
| Suicide Attempt |
5.5% |
| Fall |
4.8% |
| Drug Abuse |
4.1% |
| Mental Disorder |
3.4% |
| Pyrexia |
3.4% |
| Convulsion |
2.8% |
| Feeling Abnormal |
2.8% |
| Pain In Extremity |
2.8% |
| Product Substitution Issue |
2.8% |
| Gait Disturbance |
2.1% |
| Headache |
2.1% |
| Mitral Valve Replacement |
2.1% |
| Nausea |
2.1% |
| Tremor |
2.1% |
| Ventricular Fibrillation |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.5% |
| Hypertension |
23.5% |
| Pain |
13.0% |
| Supplementation Therapy |
4.7% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Product Used For Unknown Indication |
3.3% |
| Psoas Abscess |
2.7% |
| Prophylaxis |
2.5% |
| Colon Cancer |
1.8% |
| Drug Abuse |
1.8% |
| Sedation |
1.5% |
| Hyperglycaemia |
1.3% |
| Secretion Discharge |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Alcohol Withdrawal Syndrome |
1.2% |
| Angina Pectoris |
1.2% |
| Coronary Artery Disease |
1.2% |
| Osteoporosis |
1.2% |
| Rash |
1.2% |
|
| Anaemia |
8.8% |
| Somnolence |
8.8% |
| Poisoning Deliberate |
7.4% |
| Suicide Attempt |
7.4% |
| Weight Decreased |
7.4% |
| Drug Ineffective |
5.9% |
| Hypertension |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Blood Pressure Increased |
4.4% |
| Completed Suicide |
4.4% |
| Hypersomnia |
4.4% |
| Respiratory Arrest |
4.4% |
| Sudden Death |
4.4% |
| Blood Pressure Decreased |
2.9% |
| Blood Pressure Inadequately Controlled |
2.9% |
| Bradycardia |
2.9% |
| Coronary Artery Stenosis |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Dyspnoea |
2.9% |
| Gait Disturbance |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.8% |
| Drug Use For Unknown Indication |
24.9% |
| Hypertension |
11.7% |
| Pain |
3.7% |
| Bipolar Disorder |
3.1% |
| Depression |
3.0% |
| Diabetes Mellitus |
3.0% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Convulsion |
2.5% |
| Blood Pressure |
2.4% |
| Cardiac Disorder |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Renal Transplant |
1.9% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Anxiety |
1.7% |
| Agitation |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Insomnia |
1.3% |
| Post Laminectomy Syndrome |
1.1% |
| Atrial Fibrillation |
1.1% |
|
| Type 2 Diabetes Mellitus |
11.1% |
| Vomiting |
9.0% |
| Weight Decreased |
8.1% |
| Pneumonia |
7.3% |
| Weight Increased |
6.0% |
| Death |
5.1% |
| Pain |
4.7% |
| Myocardial Infarction |
4.3% |
| Nausea |
4.3% |
| Pain In Extremity |
4.3% |
| Rash |
4.3% |
| Renal Failure |
4.3% |
| Urticaria |
4.3% |
| Vision Blurred |
4.3% |
| White Blood Cell Count Increased |
3.8% |
| Tremor |
3.4% |
| Urinary Tract Infection |
3.4% |
| Sensory Loss |
3.0% |
| Cerebrovascular Accident |
2.6% |
| Malaise |
2.6% |
|
| Interacting |
| Epilepsy |
26.1% |
| Product Used For Unknown Indication |
26.1% |
| Abnormal Behaviour |
13.0% |
| Anaesthesia |
13.0% |
| Restless Legs Syndrome |
10.9% |
| Aggression |
8.7% |
| Anaesthetic Premedication |
2.2% |
|
| Sudden Unexplained Death In Epilepsy |
40.0% |
| Drug Interaction |
20.0% |
| Autism |
10.0% |
| Fall |
10.0% |
| Infectious Peritonitis |
10.0% |
| Somnolence |
10.0% |
|
